New Delhi [India], December 2 (ANI): After phase 2/3 clinical trials for Sputnik V commenced in India on Tuesday, Russian Ambassador Nikolay Kudashev said comprehensive cooperation in countering the spread of coronavirus is a priority area of the Russia-India bilateral and multilateral strat
New Delhi [India], December 1 (ANI): Phase 2/3 clinical trials for Sputnik V, the first registered Covid-19 vaccine from Russia commenced in India on Tuesday.
Washington [US], December 1 (ANI): Researchers from multiple institutions in North America have developed a fully automated, deep-learning (DL), artificial-intelligence clinical tool that can measure the volume of cerebral ventricles on magnetic resonance images (MRIs) in children within abo
Geneva [Switzerland], November 28 (ANI/Sputnik): Mariangela Simao, the World Health Organization's (WHO) assistant director-general for access to medicines and health products, said on Friday that the exchange of clinical data and best practices of COVID-19 vaccine manufacturing remained cru
New Delhi [India], November 26 (ANI/India PR Distribution): Tatiana Cutelli is a well-known expert and facial coach in Italy. She has treated more than 15,000 clients throughout her career.
Moscow [Russia], November 24 (ANI): The developers of Sputnik V coronavirus vaccine announced on Tuesday that it had an efficacy rate or 95 per cent based on the second interim analysis of clinical data.
Mumbai (Maharashtra) [India], November 23 (ANI/PRNewswire): The oral antiviral medication Favipiravir, that prevents the replication phase of the virus life-cycle, leads to significant improvement in clinical cure in patients with mild to moderate COVID-19.
New Delhi [India], November 23 (ANI): With an efficacy of around 90 per cent positive results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil the vaccine has proved to be highly effective in preventing COVID-19, said AstraZeneca on Monday.
New Delhi [India], November 19 (ANI): In a major development, UK's Covid-19 vaccine has shown similar strong immune response in healthy older adults -aged 56 years and above- to those seen in people between 18 to 55 years, according to findings from a phase-2 trial.
Madrid [Spain], November 18 (ANI/Sputnik): The Spanish Agency of Medicines and Medical Devices (AEMPS) authorized phase 3 clinical trials of the COVID-19 vaccine developed by Janssen, a subsidiary of the Johnson & Johnson company, the Spanish Health Ministry said on Wednesday.
New Delhi [India], November 18 (ANI): Haryana Health Minister Anil Vij has offered to become the "first volunteer" for Phase-III clinical trial of Bharat Biotech's COVID-19 vaccine 'Covaxin', which will begin in Haryana from November 20.
Geneva [Switzerland], November 16 (ANI/Sputnik): The World Health Organization (WHO) is encouraged to hear the announcement of the US biotech firm, Moderna, about the efficacy results of its coronavirus vaccine during its phase three clinical trials, its press office said on Monday.